Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), is successfully listed on the Hong Kong Stock Exchange today, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback